245 related articles for article (PubMed ID: 25928518)
21. Prebiopsy multiparametric 3T prostate MRI in patients with elevated PSA, normal digital rectal examination, and no previous biopsy.
Jambor I; Kähkönen E; Taimen P; Merisaari H; Saunavaara J; Alanen K; Obsitnik B; Minn H; Lehotska V; Aronen HJ
J Magn Reson Imaging; 2015 May; 41(5):1394-404. PubMed ID: 24956412
[TBL] [Abstract][Full Text] [Related]
22. How good is post-biopsy multiparametric magnetic resonance imaging in detecting and characterising the index lesion of localised prostate cancer?
Engelhard K; Labanaris AP; Bogner K; Lübke L; Dworak O; Kühn R
Scand J Urol; 2014 Dec; 48(6):499-505. PubMed ID: 24754780
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of suspected soft tissue lesion in the prostate bed after radical prostatectomy using 3T multiparametric magnetic resonance imaging.
Cha D; Kim CK; Park SY; Park JJ; Park BK
Magn Reson Imaging; 2015 May; 33(4):407-12. PubMed ID: 25527395
[TBL] [Abstract][Full Text] [Related]
24. Preoperative assessment of prostate cancer using prebiopsy MRI.
Min JH; Park BK; Park JJ; Park SY; Kim CK
AJR Am J Roentgenol; 2014 Aug; 203(2):341-6. PubMed ID: 25055269
[TBL] [Abstract][Full Text] [Related]
25. The role of pathology correlation approach in prostate cancer index lesion detection and quantitative analysis with multiparametric MRI.
Fedorov A; Penzkofer T; Hirsch MS; Flood TA; Vangel MG; Masry P; Tempany CM; Mulkern RV; Fennessy FM
Acad Radiol; 2015 May; 22(5):548-55. PubMed ID: 25683501
[TBL] [Abstract][Full Text] [Related]
26. Location of Prostate Cancers Determined by Multiparametric and MRI-Guided Biopsy in Patients With Elevated Prostate-Specific Antigen Level and at Least One Negative Transrectal Ultrasound-Guided Biopsy.
Schouten MG; Hoeks CM; Bomers JG; Hulsbergen-van de Kaa CA; Witjes JA; Thompson LC; Rovers MM; Barentsz JO; Fütterer JJ
AJR Am J Roentgenol; 2015 Jul; 205(1):57-63. PubMed ID: 26102380
[TBL] [Abstract][Full Text] [Related]
27. Multiparametric magnetic resonance imaging for the assessment of extracapsular invasion and other staging parameters in patients with prostate cancer candidates for radical prostatectomy.
Lista F; Gimbernat H; Cáceres F; Rodríguez-Barbero JM; Castillo E; Angulo JC
Actas Urol Esp; 2014 Jun; 38(5):290-7. PubMed ID: 24387827
[TBL] [Abstract][Full Text] [Related]
28. Early localization of recurrent prostate cancer after prostatectomy by endorectal coil magnetic resonance imaging.
Linder BJ; Kawashima A; Woodrum DA; Tollefson MK; Karnes J; Davis BJ; Rangel LJ; King BF; Mynderse LA
Can J Urol; 2014 Jun; 21(3):7283-9. PubMed ID: 24978358
[TBL] [Abstract][Full Text] [Related]
29. Fusion of Magnetic Resonance Imaging and Real-Time Elastography to Visualize Prostate Cancer: A Prospective Analysis using Whole Mount Sections after Radical Prostatectomy.
Brock M; Roghmann F; Sonntag C; Sommerer F; Tian Z; Löppenberg B; Palisaar RJ; Noldus J; Hanske J; von Bodman C
Ultraschall Med; 2015 Aug; 36(4):355-61. PubMed ID: 24854132
[TBL] [Abstract][Full Text] [Related]
30. Final Gleason score prediction using discriminant analysis and support vector machine based on preoperative multiparametric MR imaging of prostate cancer at 3T.
Citak-Er F; Vural M; Acar O; Esen T; Onay A; Ozturk-Isik E
Biomed Res Int; 2014; 2014():690787. PubMed ID: 25544944
[TBL] [Abstract][Full Text] [Related]
31. The value of ADC, T2 signal intensity, and a combination of both parameters to assess Gleason score and primary Gleason grades in patients with known prostate cancer.
Nowak J; Malzahn U; Baur AD; Reichelt U; Franiel T; Hamm B; Durmus T
Acta Radiol; 2016 Jan; 57(1):107-14. PubMed ID: 25505225
[TBL] [Abstract][Full Text] [Related]
32. Prospective evaluation of magnetic resonance imaging guided in-bore prostate biopsy versus systematic transrectal ultrasound guided prostate biopsy in biopsy naïve men with elevated prostate specific antigen.
Quentin M; Blondin D; Arsov C; Schimmöller L; Hiester A; Godehardt E; Albers P; Antoch G; Rabenalt R
J Urol; 2014 Nov; 192(5):1374-9. PubMed ID: 24866597
[TBL] [Abstract][Full Text] [Related]
33. T2-weighted hypointense lesions within prostate gland: differential diagnosis using wash-in rate parameter on the basis of dynamic contrast-enhanced magnetic resonance imaging--hystopatology correlations.
Valentini AL; Gui B; Cina A; Pinto F; Totaro A; Pierconti F; Bassi PF; Bonomo L
Eur J Radiol; 2012 Nov; 81(11):3090-5. PubMed ID: 22727777
[TBL] [Abstract][Full Text] [Related]
34. Prostate cancer detection in patients with total serum prostate-specific antigen levels of 4-10 ng/mL: diagnostic efficacy of diffusion-weighted imaging, dynamic contrast-enhanced MRI, and T2-weighted imaging.
Tamada T; Sone T; Higashi H; Jo Y; Yamamoto A; Kanki A; Ito K
AJR Am J Roentgenol; 2011 Sep; 197(3):664-70. PubMed ID: 21862809
[TBL] [Abstract][Full Text] [Related]
35. Decision analysis model comparing cost of multiparametric magnetic resonance imaging vs. repeat biopsy for detection of prostate cancer in men with prior negative findings on biopsy.
Lotan Y; Haddad AQ; Costa DN; Pedrosa I; Rofsky NM; Roehrborn CG
Urol Oncol; 2015 Jun; 33(6):266.e9-16. PubMed ID: 25858102
[TBL] [Abstract][Full Text] [Related]
36. Prostate cancer: role of pretreatment multiparametric 3-T MRI in predicting biochemical recurrence after radical prostatectomy.
Park JJ; Kim CK; Park SY; Park BK; Lee HM; Cho SW
AJR Am J Roentgenol; 2014 May; 202(5):W459-65. PubMed ID: 24758681
[TBL] [Abstract][Full Text] [Related]
37. MR-guided prostate biopsy for planning of focal salvage after radiation therapy.
Ménard C; Iupati D; Publicover J; Lee J; Abed J; O'Leary G; Simeonov A; Foltz WD; Milosevic M; Catton C; Morton G; Bristow R; Bayley A; Atenafu EG; Evans AJ; Jaffray DA; Chung P; Brock KK; Haider MA
Radiology; 2015 Jan; 274(1):181-91. PubMed ID: 25203127
[TBL] [Abstract][Full Text] [Related]
38. Predictors of unfavorable disease after radical prostatectomy in patients at low risk by D'Amico criteria: role of multiparametric magnetic resonance imaging.
Song SH; Pak S; Park S; Song C; Jeong IG; Choi HJ; Kim JK; Cho KS; Kim CS; Ahn H
J Urol; 2014 Aug; 192(2):402-8. PubMed ID: 24631106
[TBL] [Abstract][Full Text] [Related]
39. A role of multifactorial evaluation of prostatic 3T MRI in patients with elevated prostatic-specific antigen levels: prospective comparison with ultrasound-guided transrectal biopsy.
Ferda J; Kastner J; Hora M; Hes O; Fínek J; Topolčan O; Kreuzberg B
Anticancer Res; 2013 Jun; 33(6):2791-5. PubMed ID: 23749943
[TBL] [Abstract][Full Text] [Related]
40. Multiparametric magnetic resonance imaging vs. standard care in men being evaluated for prostate cancer: a randomized study.
Panebianco V; Barchetti F; Sciarra A; Ciardi A; Indino EL; Papalia R; Gallucci M; Tombolini V; Gentile V; Catalano C
Urol Oncol; 2015 Jan; 33(1):17.e1-17.e7. PubMed ID: 25443268
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
